通过抑制病毒复制复合体的凝聚,MERS-CoV对抗PKR激活
bioRxiv : the preprint server for biology
|September 2, 2025
概括
中东呼吸综合征冠状病毒 (MERS-CoV) 对抗蛋白激酶R (PKR) 途径. MERS-CoV NS4a 蛋白质通过阻断病毒 dsRNA 上的 PKR 凝结来防止 PKR 激活,这是先天免疫的关键步骤.
科学领域:
- 病毒学
- 免疫学
- 分子生物学
背景情况:
- 中东呼吸综合征冠状病毒 (MERS-CoV) 是一种抑制天生的免疫反应的病原病毒.
- 蛋白激酶R (PKR) 途径是MERS-CoV所针对的先天免疫系统的关键组成部分.
研究的目的:
- 调查PKR激活在对MERS-CoV的反应中的机制.
- 阐明MERS-CoV如何对抗PKR途径.
主要方法:
- 使用一种免疫刺激的MERS-CoV突变体,其中含有无活性的核激酶U和辅助蛋白NS4a的删除.
- 观察到与双膜囊泡 (DMV) 相关的病毒dRNA的PKR凝聚和激活.
- 研究了MERS-CoV NS4a蛋白在PKR抑制中的作用.
主要成果:
- 通过在DMV附近的病毒dSRNA上凝聚,PKR被激活,然后解离为eIF2α.
- 通过与dsRNA结合并防止PKR凝聚,MERS-CoV NS4a蛋白抑制PKR激活.
- 在对寨卡病毒的反应中也观察到PKR凝聚和激活.
结论:
- PKR激活包括在复制复合体上的病毒dRNA的凝聚,随后是自化和细胞移位.
- 通过抑制PKR凝聚,MERS-CoV NS4a对抗这种抗病毒途径.
- 这项研究提供了正链RNA病毒和MERS-CoV免疫逃避策略的PKR激活模型.
相关概念视频
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
cAMP-dependent Protein Kinase Pathways
6.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
Eukaryotic Transcription Inhibitors
10.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K
GPCR Desensitization
6.4K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.4K
GPCRs Regulate Adenylyl Cylase Activity
5.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K


